Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Konanda Pharma Fund I is a healthcare-focused venture capital fund that specializes in investments within the biotechnology and life sciences sectors. The fund is managed by Konanda, an investment firm known for its strategic involvement in early-stage biopharmaceutical companies. It provides capital and expertise to support the development of innovative therapies and healthcare technologies. Notable investments associated with the fund's management include positions in companies such as Aclaris Therapeutics and Intercept Pharmaceuticals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Konanda Pharma Fund I.